John D. Quisel - 10 Feb 2025 Form 4 Insider Report for Disc Medicine, Inc. (IRON)

Role
Chief Executive Officer, Director
Signature
By: /s/ Rahul Khara, as Attorney-in-Fact
Issuer symbol
IRON
Transactions as of
10 Feb 2025
Net transactions value
$0
Form type
4
Filing time
12 Feb 2025, 18:35:51 UTC
Previous filing
02 Jan 2025
Next filing
20 Feb 2025
SEC
View on sec.gov

Key filing fact

John D. Quisel filed Form 4 for Disc Medicine, Inc. (IRON) on 12 Feb 2025.

Key facts

  • This page summarizes John D. Quisel's Form 4 filing for Disc Medicine, Inc. (IRON).
  • 2 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 12 Feb 2025, 18:35.

Change

  • Previous filing in this sequence was filed on 02 Jan 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

IRON transaction

Common Stock

Award

Transaction value
$0
Shares
+78,337
Change %
+95%
Price
$0.000000
Shares after
160,402
Date
10 Feb 2025
Ownership
Direct
Footnotes
F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

IRON transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+117,505
Change %
Price
$0.000000
Shares after
117,505
Date
10 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
117,505
Exercise price
$54.71
Footnotes
F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest annually in four 25% installments commencing on February 15, 2026, subject to the Reporting Person's continued service on each such vesting date.
F2 The shares underlying this option vest in 48 equal monthly installments commencing on March 10, 2025, subject to the Reporting Person's continuted service on each such vesting date.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .